Sigyn Therapeutics (SIGY) News Today $3.15 0.00 (0.00%) (As of 12/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Sigyn Therapeutics, Inc. (SIGY)December 21 at 3:30 PM | finance.yahoo.comPresenting on the Emerging Growth Conference 76 Day 2 on October 31 Register NowOctober 30, 2024 | markets.businessinsider.comPresenting on the Emerging Growth Conference 74 Day 2 on August 22 Register NowAugust 21, 2024 | finance.yahoo.comOTCQB Venture Virtual Investor Conference Presentations Now Available for On-Demand ViewingAugust 2, 2024 | finance.yahoo.comSigyn Therapeutics Reports First Quarter 2024 Financial ResultsMay 15, 2024 | finance.yahoo.comSigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections"May 7, 2024 | finance.yahoo.comSigyn Therapeutics™ to Present at Tomorrow’s Emerging Growth ConferenceMarch 5, 2024 | finance.yahoo.comSigyn Therapeutics to Present at Tomorrow's Emerging Growth ConferenceMarch 5, 2024 | finance.yahoo.comSigyn Therapeutics™ to Present at Tomorrow's Emerging Growth ConferenceMarch 5, 2024 | globenewswire.comSigyn Therapeutics™ Announces Filing of 2023 Annual Report on SEC Form 10-KFebruary 21, 2024 | globenewswire.comSigyn Therapeutics, Inc.: Sigyn Therapeutics Completes Reverse Stock SplitFebruary 3, 2024 | finanznachrichten.deSigyn Therapeutics Announces 1-for-40 Reverse Stock SplitFebruary 2, 2024 | msn.comSigyn Therapeutics Completes Reverse Stock SplitFebruary 1, 2024 | finance.yahoo.comSigyn Therapeutics, Inc.: Sigyn Therapeutics Announces Reverse Stock SplitJanuary 30, 2024 | finanznachrichten.deSigyn Therapeutics, Inc.: Sigyn Therapeutics Releases Letter to ShareholdersJanuary 30, 2024 | finanznachrichten.deEQS-News: Sigyn Therapeutics Announces Reverse Stock SplitJanuary 30, 2024 | markets.businessinsider.comSigyn Therapeutics Announces Reverse Stock SplitJanuary 30, 2024 | finance.yahoo.comSigyn Therapeutics Releases Letter to ShareholdersJanuary 4, 2024 | finance.yahoo.comSigyn Therapeutics, Inc.: Sigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial OfficerDecember 12, 2023 | finanznachrichten.deSigyn Therapeutics appoints Jerry DeCiccio as finance chiefDecember 12, 2023 | msn.comSigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial OfficerDecember 12, 2023 | finance.yahoo.comSigyn Therapeutics, Inc.: Sigyn Therapeutics Reports Third Quarter 2023 Financial ResultsNovember 15, 2023 | finanznachrichten.deSigyn Therapeutics Inc GAAP EPS of -$0.02November 15, 2023 | msn.comSigyn Therapeutics Reports Third Quarter 2023 Financial ResultsNovember 14, 2023 | finance.yahoo.comSigyn Therapeutics™ Discloses PCT Patent Submission to Enhance Chemotherapy Delivery and Reduce Cancer Treatment ToxicityOctober 4, 2023 | finance.yahoo.comSigyn Therapeutics to Present at Today’s Emerging Growth Conference and Tomorrow at the National Investment Bankers Association ConferenceSeptember 15, 2023 | finance.yahoo.comRelay Therapeutics Inc Ordinary SharesJune 23, 2023 | morningstar.comBeam Therapeutics (NASDAQ: BEAM)May 22, 2023 | fool.comSigyn Therapeutics Discloses “DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES” Patent Submission and Related ImmunePrep™ Trademark ApplicationMay 17, 2023 | finance.yahoo.comSigyn Therapeutics, Inc.: Sigyn Therapeutics Reports First Quarter 2023 Financial ResultsMay 16, 2023 | finanznachrichten.deSigyn Therapeutics Reports First Quarter 2023 Financial ResultsMay 16, 2023 | finance.yahoo.comSigyn Therapeutics™ Announces Appointment of Annette Marleau, Ph.D. as Chief Scientific OfficerApril 11, 2023 | finance.yahoo.comSigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-KMarch 31, 2023 | finance.yahoo.comChinook TherapeuticsMarch 21, 2023 | forbes.comJounce Therapeutics downgraded to market perform at Raymond James on company restructuringFebruary 25, 2023 | seekingalpha.com Get Sigyn Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SIGY and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now SIGY Media Mentions By Week SIGY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SIGY News Sentiment▼0.000.60▲Average Medical News Sentiment SIGY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SIGY Articles This Week▼10▲SIGY Articles Average Week Get Sigyn Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SIGY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Neuronetics News Precision Optics News IRIDEX News Femasys News Co-Diagnostics News DarioHealth News NEXGEL News Allurion Technologies News BioSig Technologies News Vivos Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SIGY) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sigyn Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sigyn Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.